Medifast (MED) Stock Forecast, Price Target & Predictions
MED Stock Forecast
Medifast stock forecast is as follows: an average price target of $17.00 (represents a 0.47% upside from MED’s last price of $16.92) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.
MED Price Target
The average price target for Medifast (MED) is $17.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $17.00 to $17.00. This represents a potential 0.47% upside from MED's last price of $16.92.
MED Analyst Ratings
According to 3 Wall Street analysts, Medifast's rating consensus is 'Hold'. The analyst rating breakdown for MED stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 2 'Hold' (66.67%), 1 'Sell' (33.33%), and 0 'Strong Sell' (0.00%).
Medifast Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 05, 2024 | Linda Bolton Weiser | D.A. Davidson | $17.00 | $20.40 | -16.67% | 0.47% |
| Jun 05, 2024 | Linda Bolton Weiser | D.A. Davidson | $17.50 | $23.97 | -26.99% | 3.43% |
| Apr 30, 2024 | Linda Bolton Weiser | D.A. Davidson | $25.00 | $35.51 | -29.60% | 47.75% |
| Jun 05, 2023 | Stephanie Wissink | Jefferies | $150.00 | $81.22 | 84.68% | 786.52% |
| Apr 06, 2023 | Linda Bolton Weiser | D.A. Davidson | $94.00 | $96.39 | -2.48% | 455.56% |
The latest Medifast stock forecast, released on Nov 05, 2024 by Linda Bolton Weiser from D.A. Davidson, set a price target of $17.00, which represents a -16.67% decrease from the stock price at the time of the forecast ($20.40), and a 0.47% increase from MED last price ($16.92).
Medifast Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 3 |
| Avg Price Target | - | $17.00 | $19.83 |
| Last Closing Price | $16.92 | $16.92 | $16.92 |
| Upside/Downside | -100.00% | 0.47% | 17.20% |
In the current month, the average price target of Medifast stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Medifast's last price of $16.92. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 22, 2023 | Citigroup | Hold | Hold | Hold |
| Jun 21, 2023 | Citigroup | Neutral | Neutral | Hold |
| Nov 04, 2022 | Redburn Partners | Sell | Initialise | |
| Aug 04, 2022 | Jefferies | Hold | Downgrade |
Medifast's last stock rating was published by Citigroup on Sep 22, 2023. The company gave MED a "Hold" rating, the same as its previous rate.
Medifast Financial Forecast
Medifast Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $235.87M | $296.19M | $348.98M | $337.25M | $390.40M | $453.33M | $417.60M | $377.83M | $413.39M | $394.19M | $340.67M | $264.91M | $271.47M | $220.00M | $178.46M | $170.63M | $190.06M |
| Avg Forecast | $130.80M | $128.20M | $125.70M | $124.50M | $116.60M | $130.65M | $131.75M | $130.75M | $114.25M | $138.15M | $174.05M | $173.45M | $184.17M | $232.10M | $270.20M | $319.52M | $330.07M | $349.30M | $455.00M | $403.27M | $375.79M | $405.67M | $359.53M | $278.89M | $249.22M | $240.63M | $191.75M | $165.71M | $161.68M | $195.15M |
| High Forecast | $136.29M | $133.58M | $130.97M | $129.72M | $121.49M | $136.13M | $137.28M | $136.24M | $119.04M | $140.15M | $181.35M | $175.72M | $191.90M | $234.20M | $281.54M | $332.92M | $343.92M | $349.30M | $455.00M | $403.27M | $375.79M | $405.67M | $359.53M | $278.89M | $249.22M | $240.63M | $191.75M | $165.71M | $161.68M | $195.15M |
| Low Forecast | $125.31M | $122.82M | $120.43M | $119.28M | $111.71M | $125.17M | $126.22M | $125.26M | $109.46M | $136.15M | $166.75M | $171.18M | $176.44M | $230.00M | $258.86M | $306.11M | $316.22M | $349.30M | $455.00M | $403.27M | $375.79M | $405.67M | $359.53M | $278.89M | $249.22M | $240.63M | $191.75M | $165.71M | $161.68M | $195.15M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 5 | 4 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.10% | 1.09% | 1.02% | 1.12% | 1.00% | 1.04% | 1.01% | 1.02% | 1.10% | 1.22% | 1.06% | 1.13% | 1.15% | 1.08% | 1.06% | 0.97% |
Medifast's average Quarter revenue forecast for Dec 23 based on 1 analysts is $184.17M, with a low forecast of $176.44M, and a high forecast of $191.90M. MED's average Quarter revenue forecast represents a -21.92% decrease compared to the company's last Quarter revenue of $235.87M (Sep 23).
Medifast EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 5 | 4 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $25.51M | $42.07M | $56.48M | $35.59M | $50.99M | $51.69M | $57.53M | $46.20M | $57.73M | $63.91M | $54.88M | $39.90M | $46.45M | $30.04M | $25.39M | $20.48M | $22.11M |
| Avg Forecast | $17.79M | $17.44M | $17.10M | $16.93M | $15.86M | $17.77M | $17.92M | $17.78M | $15.54M | $18.79M | $23.67M | $68.97M | $25.05M | $31.57M | $36.75M | $62.70M | $45.92M | $46.80M | $60.96M | $57.00M | $50.34M | $54.35M | $48.17M | $40.19M | $33.39M | $32.24M | $25.69M | $15.26M | $21.66M | $26.14M |
| High Forecast | $18.54M | $18.17M | $17.82M | $17.65M | $16.53M | $18.52M | $18.67M | $18.53M | $16.19M | $19.06M | $24.67M | $82.77M | $26.10M | $31.86M | $38.30M | $75.25M | $55.11M | $46.80M | $60.96M | $68.40M | $50.34M | $54.35M | $48.17M | $48.22M | $33.39M | $32.24M | $25.69M | $18.32M | $21.66M | $26.14M |
| Low Forecast | $17.05M | $16.71M | $16.38M | $16.22M | $15.19M | $17.03M | $17.17M | $17.04M | $14.89M | $18.52M | $22.68M | $55.18M | $24.00M | $31.28M | $35.21M | $50.16M | $36.74M | $46.80M | $60.96M | $45.60M | $50.34M | $54.35M | $48.17M | $32.15M | $33.39M | $32.24M | $25.69M | $12.21M | $21.66M | $26.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.81% | 1.14% | 0.90% | 0.78% | 1.09% | 0.85% | 1.01% | 0.92% | 1.06% | 1.33% | 1.37% | 1.19% | 1.44% | 1.17% | 1.66% | 0.95% | 0.85% |
1 analysts predict MED's average Quarter EBITDA for Dec 23 to be $25.05M, with a high of $26.10M and a low of $24.00M. This is -1.80% lower than Medifast's previous annual EBITDA (Sep 23) of $25.51M.
Medifast Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 5 | 4 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $23.13M | $30.28M | $39.97M | $26.52M | $36.16M | $39.11M | $41.78M | $34.02M | $41.98M | $46.96M | $41.06M | $27.99M | $34.45M | $21.93M | $18.48M | $19.88M | $15.90M |
| Avg Forecast | $5.27M | $2.41M | $877.68K | $-3.07M | $2.47M | $1.81M | $1.04M | $-2.08M | $-1.76M | $-2.08M | $4.26M | $50.27M | $10.56M | $11.68M | $15.80M | $45.70M | $33.75M | $20.89M | $35.82M | $41.55M | $29.02M | $33.69M | $36.27M | $30.08M | $26.01M | $26.88M | $20.04M | $11.16M | $11.76M | $14.63M |
| High Forecast | $5.55M | $2.55M | $925.56K | $-2.90M | $2.60M | $1.91M | $1.10M | $-1.97M | $-650.13K | $-1.97M | $4.27M | $60.33M | $11.13M | $12.24M | $16.66M | $54.84M | $40.50M | $20.89M | $35.82M | $49.86M | $29.02M | $33.69M | $36.27M | $36.10M | $26.01M | $26.88M | $20.04M | $13.39M | $11.76M | $14.63M |
| Low Forecast | $4.98M | $2.28M | $829.80K | $-3.24M | $2.33M | $1.71M | $985.39K | $-2.20M | $-2.80M | $-2.20M | $4.26M | $40.22M | $9.98M | $11.24M | $14.94M | $36.56M | $27.00M | $20.89M | $35.82M | $33.24M | $29.02M | $33.69M | $36.27M | $24.07M | $26.01M | $26.88M | $20.04M | $8.92M | $11.76M | $14.63M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.98% | 1.92% | 0.87% | 0.79% | 1.73% | 1.09% | 1.01% | 1.17% | 1.25% | 1.29% | 1.37% | 1.08% | 1.28% | 1.09% | 1.66% | 1.69% | 1.09% |
Medifast's average Quarter net income forecast for Dec 23 is $10.56M, with a range of $9.98M to $11.13M. MED's average Quarter net income forecast represents a -54.36% decrease compared to the company's last Quarter net income of $23.13M (Sep 23).
Medifast SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 5 | 4 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $151.87M | $172.01M | $192.88M | $201.00M | $234.69M | $272.72M | $247.20M | $231.45M | $251.89M | $232.27M | $195.75M | $161.27M | $159.48M | $131.20M | $111.71M | $109.36M | $122.67M |
| Avg Forecast | $79.22M | $77.65M | $76.13M | $75.41M | $70.62M | $79.13M | $79.80M | $79.19M | $69.20M | $83.67M | $105.42M | $105.06M | $111.55M | $140.58M | $163.65M | $270.40M | $229.61M | $211.56M | $275.58M | $245.81M | $227.61M | $245.70M | $217.76M | $143.41M | $150.95M | $145.74M | $116.14M | $67.44M | $97.92M | $118.20M |
| High Forecast | $82.55M | $80.91M | $79.33M | $78.57M | $73.59M | $82.45M | $83.15M | $82.52M | $72.10M | $84.89M | $109.84M | $106.43M | $116.23M | $141.85M | $170.52M | $324.47M | $275.54M | $211.56M | $275.58M | $294.98M | $227.61M | $245.70M | $217.76M | $172.09M | $150.95M | $145.74M | $116.14M | $80.93M | $97.92M | $118.20M |
| Low Forecast | $75.90M | $74.39M | $72.94M | $72.24M | $67.66M | $75.81M | $76.45M | $75.87M | $66.30M | $82.46M | $100.99M | $103.68M | $106.87M | $139.31M | $156.79M | $216.32M | $183.69M | $211.56M | $275.58M | $196.65M | $227.61M | $245.70M | $217.76M | $114.72M | $150.95M | $145.74M | $116.14M | $53.96M | $97.92M | $118.20M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.05% | 0.71% | 0.88% | 1.11% | 0.99% | 1.01% | 1.02% | 1.03% | 1.07% | 1.37% | 1.07% | 1.09% | 1.13% | 1.66% | 1.12% | 1.04% |
Medifast's average Quarter SG&A projection for Dec 23 is $111.55M, based on 1 Wall Street analysts, with a range of $106.87M to $116.23M. The forecast indicates a -26.55% fall compared to MED last annual SG&A of $151.87M (Sep 23).
Medifast EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 5 | 4 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.12 | $2.78 | $3.68 | $2.42 | $3.30 | $3.44 | $3.62 | $2.91 | $3.59 | $4.00 | $3.49 | $2.38 | $2.93 | $1.86 | $1.57 | $1.71 | $1.36 |
| Avg Forecast | $0.48 | $0.22 | $0.08 | $-0.28 | $0.23 | $0.17 | $0.10 | $-0.19 | $-0.16 | $-0.19 | $0.39 | $0.80 | $0.96 | $1.06 | $1.44 | $2.40 | $2.22 | $1.91 | $3.27 | $3.57 | $2.65 | $3.08 | $3.32 | $2.73 | $2.38 | $2.46 | $1.83 | $1.33 | $1.07 | $1.34 |
| High Forecast | $0.51 | $0.23 | $0.08 | $-0.26 | $0.24 | $0.17 | $0.10 | $-0.18 | $-0.06 | $-0.18 | $0.39 | $0.81 | $1.01 | $1.12 | $1.52 | $2.53 | $2.34 | $1.91 | $3.27 | $3.57 | $2.65 | $3.08 | $3.32 | $2.73 | $2.38 | $2.46 | $1.83 | $1.33 | $1.07 | $1.34 |
| Low Forecast | $0.45 | $0.21 | $0.08 | $-0.30 | $0.21 | $0.16 | $0.09 | $-0.20 | $-0.25 | $-0.20 | $0.39 | $0.79 | $0.91 | $1.02 | $1.36 | $2.27 | $2.10 | $1.91 | $3.27 | $3.57 | $2.65 | $3.08 | $3.32 | $2.73 | $2.38 | $2.46 | $1.83 | $1.33 | $1.07 | $1.34 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.99% | 1.93% | 1.53% | 1.09% | 1.73% | 1.05% | 1.01% | 1.10% | 1.17% | 1.21% | 1.28% | 1.00% | 1.19% | 1.02% | 1.18% | 1.59% | 1.02% |
According to 1 Wall Street analysts, Medifast's projected average Quarter EPS for Dec 23 is $0.96, with a low estimate of $0.91 and a high estimate of $1.01. This represents a -54.61% decrease compared to MED previous annual EPS of $2.12 (Sep 23).
Medifast Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| MCW | Mister Car Wash | $7.37 | $10.00 | 35.69% | Hold |
| BFAM | Bright Horizons Family Solutions | $108.14 | $145.50 | 34.55% | Buy |
| ROL | Rollins | $48.22 | $52.67 | 9.23% | Buy |
| SCI | Service Corporation | $85.12 | $84.00 | -1.32% | Buy |
| CSV | Carriage Services | $41.08 | $40.00 | -2.63% | Buy |
| MED | Medifast | $18.59 | $17.00 | -8.55% | Hold |
| HRB | H&R Block | $54.65 | $33.30 | -39.07% | Sell |